Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

3.29
Delayed Data
As of Jun 28
 -0.04 / -1.20%
Today’s Change
1.22
Today|||52-Week Range
5.55
+131.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues575.0K1.1M989.7K575.0K
 
 
 
 
 
Depreciation And Amortization14.9K12.1K21.9K5.7K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses2.1M1.8M2.8M2.2M
 
 
 
 
 
Research And Development1.3M1.1M2.2M1.4M
 
 
 
 
 
Total Operating Expenses2.1M1.9M2.8M2.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.5M-714.1K-1.8M-1.6M
 
 
 
 
 
Extraordinary Credit0.001.8M399.4K0.00
 
 
 
Extraordinary Charge-547.2K0.000.00-121.7K
 
 
 
Other Expenses33.1K-22.2K271.2K-8.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M1.1M-1.2M-1.7M
 
 
 
 
 
Minority Interest-11.5K-2.1K-57.9K-36.4K
 
 
 
 
 
Net Income-1.9M1.1M-1.2M-1.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.0M11.0M11.0M11.0M
 
 
 
 
 
Shares To Calculate EPS Diluted11.0M11.0M11.0M11.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17$0.10-$0.11-$0.15
 
 
 
 
 
EPS Diluted-$0.17$0.10-$0.11-$0.15